14 Jun 2021
14:11 E.S.T.

Cellectis’ Innovation Days event highlighted New Product Development,  New Genome Surgery Platform .HEAL, and Manufacturing Capabilities

Read more

02 Jun 2021
02:35 E.S.T.

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 1, 2021

Read more

11 May 2021
13:05 E.S.T.

Cellectis and Sanofi partner on alemtuzumab as lymphodepletion agent for allogeneic CAR-T

Read more

06 May 2021
14:28 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2021

Read more

26 Apr 2021
15:06 E.S.T.

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 1, 2021

Read more

09 Apr 2021
00:00 E.S.T.

Cellectis Completes Sale of $47 million through its ATM program

Read more